Benzetimide hydrochloride
Code | Size | Price |
---|
TAR-T7561-10mg | 10mg | £109.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T7561-1mL | 1 mL * 10 mM (in DMSO) | £114.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T7561-25mg | 25mg | £131.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T7561-50mg | 50mg | £152.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T7561-100mg | 100mg | £176.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Benzetimide hydrochloride is an antagonist of muscarinic acetylcholine receptor.treatment neuroleptic-induced parkinsonism.
CAS:
5633-14-7
Formula:
C23H27ClN2O2
Molecular Weight:
398.93
Pathway:
Neuroscience
Purity:
0.98
SMILES:
Cl.O=C1CCC(C2CCN(Cc3ccccc3)CC2)(C(=O)N1)c1ccccc1
Target:
AChR
References
Klaassen A B M , Kuijpers W , Scheres H M E , et al. Cholinergic Receptors in the Upper Respiratory System of the Rat[J]. Archives of Otolaryngology - Head and Neck Surgery, 1986, 112(4):428-431.
Kovacs I , Yamamura H I , Waite S L , et al. Pharmacological comparison of the cloned rat and human M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line[J]. Journal of Pharmacology and Experimental Therapeutics, 1998, 284(2):500-507.